ArticleInternational journal of nanomedicine2026

An E3 Aptamer-Modified T Cell-Derived Exosomal Nanoplatform for Codelivery of Astragaloside IV and PESV: Enhancing Prostate Cancer Therapy Through Immune Modulation with Implications for Clinical Translation.

Qing Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.